Cano Health ROA 2020-2024 | CANOQ
Current and historical return on assets (ROA) values for Cano Health (CANOQ) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Cano Health ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-03-31 | $-0.98B | $1.05B | -78.89% |
| 2023-12-31 | $-0.59B | $1.01B | -40.43% |
| 2023-09-30 | $-0.58B | $1.21B | -33.98% |
| 2023-06-30 | $-0.37B | $1.71B | -19.08% |
| 2023-03-31 | $-0.24B | $1.94B | -11.45% |
| 2022-12-31 | $-0.21B | $1.93B | -9.77% |
| 2022-09-30 | $-0.04B | $2.20B | -1.90% |
| 2022-06-30 | $-0.01B | $2.14B | -0.47% |
| 2022-03-31 | $0.00B | $2.17B | 0.00% |
| 2021-12-31 | $-0.02B | $2.14B | -1.03% |
| 2021-09-30 | $-0.08B | $2.14B | -6.50% |
| 2021-06-30 | $-0.07B | $1.66B | -7.77% |
| 2021-03-31 | $-0.09B | $0.69B | -12.94% |
| 2020-12-31 | $-0.07B | $0.61B | -14.21% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.001B | $3.138B |
| Cano Health Inc. is a value-based primary care provider for seniors and underserved communities. It provides health management programs including telehealth, prescription home delivery, wellness programs, transition of care and high-risk and complex care management. Cano Health Inc., formerly known as Jaws Acquisition Corp., is based in MIAMI. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $127.732B | 15.57 |
| Cencora (COR) | United States | $47.268B | 18.06 |
| ICON (ICLR) | Ireland | $24.749B | 22.24 |
| DiDi Global (DIDIY) | China | $18.956B | 0.00 |
| Avantor (AVTR) | United States | $18.274B | 27.71 |
| Natera (NTRA) | United States | $15.647B | 0.00 |
| Revvity (RVTY) | United States | $15.051B | 26.36 |
| Viatris (VTRS) | United States | $13.916B | 4.24 |
| CochLear (CHEOY) | Australia | $12.791B | 0.00 |
| Solventum (SOLV) | United States | $12.090B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.902B | 33.08 |
| Charles River Laboratories (CRL) | United States | $10.254B | 19.38 |
| Sonic Healthcare (SKHHY) | Australia | $8.738B | 0.00 |
| Doximity (DOCS) | United States | $7.300B | 46.26 |
| HealthEquity (HQY) | United States | $6.831B | 37.08 |
| PACS (PACS) | United States | $6.206B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.474B | 23.56 |
| Organon (OGN) | United States | $5.270B | 5.36 |
| Life Times (LTH) | United States | $4.983B | 41.65 |
| Sotera Health (SHC) | United States | $4.758B | 24.00 |
| Surgery Partners (SGRY) | United States | $3.941B | 43.66 |
| GoodRx Holdings (GDRX) | United States | $2.941B | 110.71 |
| Concentras Parent (CON) | United States | $2.927B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.591B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $2.375B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.275B | 0.00 |
| Progyny (PGNY) | United States | $2.180B | 38.33 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.064B | 0.00 |
| Premier (PINC) | United States | $2.033B | 9.14 |
| AMN Healthcare Services Inc (AMN) | United States | $1.791B | 9.00 |
| CareDx (CDNA) | United States | $1.523B | 0.00 |
| Agilon Health (AGL) | United States | $1.453B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.385B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.235B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $1.020B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.939B | 10.21 |
| QDM (QDMI) | Hong Kong, SAR China | $0.933B | 24.43 |
| Embecta (EMBC) | United States | $0.924B | 6.16 |
| InnovAge Holding (INNV) | United States | $0.812B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.540B | 0.00 |
| Sharecare (SHCR) | United States | $0.519B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.496B | 0.00 |
| Enhabit (EHAB) | United States | $0.407B | 35.22 |
| Sonida Senior Living (SNDA) | United States | $0.379B | 0.00 |
| DocGo (DCGO) | United States | $0.373B | 14.04 |
| Biodesix (BDSX) | United States | $0.257B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.256B | 0.00 |
| LifeMD (LFMD) | United States | $0.227B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.208B | 0.00 |
| ModivCare (MODV) | United States | $0.201B | 6.39 |
| Beauty Health (SKIN) | United States | $0.186B | 0.00 |
| MultiPlan (MPLN) | United States | $0.148B | 0.00 |
| Nutex Health (NUTX) | United States | $0.128B | 0.00 |
| So-Young (SY) | China | $0.087B | 21.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.081B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.058B | 0.00 |
| NeueHealth (NEUE) | United States | $0.044B | 1.74 |
| Co-Diagnostics (CODX) | United States | $0.042B | 0.00 |
| OncoCyte (OCX) | United States | $0.041B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| Oncology Institute (TOI) | United States | $0.025B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.021B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | $0.008B | 0.00 | |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |